Modified version of Figure 1A from Lin et al showing individual patient outcomes with BTKi treatment after progression while receiving venetoclax. Median PFS was 34 months. See Figure 1A in the article by Lin et al that begins on page 2266.
Modified version of Figure 1A from Lin et al showing individual patient outcomes with BTKi treatment after progression while receiving venetoclax. Median PFS was 34 months. See Figure 1A in the article by Lin et al that begins on page 2266.